ALICIA OLSON: Open Payments
NPI 1871010066 · GRAND JUNCTION, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 17 payments from 7 companies in 2025. Trend: 2023 $292 · 2024 $208 · 2025 $427
Food & beverage: $325Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $111 |
| ABBVIE INC. | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, Jornay PM, Auvelity, Qelbree, FANAPT.
Industry payments across CO — which companies pay providers there.
